DBL Vinblastine Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

The use of small amounts of vinblastine daily for long periods is not advisable, even though the resulting total dosage may be similar to the recommended dosage. Little or no therapeutic advantage has been demonstrated when such regimens have been used and side-effects are increased.
The incidence of side effects with vinblastine sulfate appears to be dose related and most do not persist longer than 24 hours. Neurologic effects are uncommon but can occur and may last longer than 24 hours.
The frequency grouping is defined using the following convention: Not known (cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. (See Table 2.)

Click on icon to see table/diagram/image

View ADR Reporting Link

DBL Vinblastine Adverse Reactions

vinblastine

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma